The effects of supplementation with blueberry (BE) extract (Vaccinium ashei Reade) for 14 consecutive days on biochemical, hematological, histopathological and oxidative parameters in hypercholesterolemic rats were investigated. After supplementation with lyophilized extract of BE, the levels of total cholesterol, low-density lipoprotein cholesterol and triglycerides were decreased. Histopathological analysis showed significant decrease (p < 0.05) of aortic lesions in hypercholesterolemic rats. Oxidative parameters showed significant reductions (p < 0.05) in oxidative damage to lipids and proteins and an increase in activities of antioxidant enzymes such as catalase, superoxide dismutase and glutathione peroxidase. The BE extract showed an important cardioprotective effect by the improvements in the serum lipid profile, antioxidant system, particularly in reducing oxidative stress associated with hypercholesterolemia and anti-atherogenic effect in rats.

Atherosclerosis is morphologically an inflammatory disease, where endothelial dysfunction plays a key role in all the stages. The nitric oxide (NO) synthase 3 (NOS3) gene is responsible for the synthesis of endothelial NO synthase (eNOS) in humans and some genetic polymorphisms are considered “polymorphisms associated with risk” for the development of coronary artery diseases, such as acute coronary syndrome. Thus, the present study aimed to evaluate the influence of the -786T>C polymorphism of the eNOS gene on inflammatory and oxidative process. A prospective cohort study of 125 consecutive patients with clinical diagnosis of non-ST-elevation acute coronary syndromes was conducted. Patients were assessed using a standardized questionnaire. Blood samples were drawn to measure serum levels of high-sensitivity C-reactive protein, soluble CD40 ligand, interleukin-6 (IL-6), N-terminal prohormone of brain natriuretic peptide, immunoglobulin G antibodies against oxidized low-density lipoprotein. The genotypes for the -786T>C polymorphism in the 5′-flanking region of eNOS gene were determined. The -786C allele was found in 92 of 250 alleles (38.8%). No statistical association was observed between demographic and clinical characteristics and distribution of eNOS-786T>C polymorphism. We found that -786CC was associated with lower levels of IL-6. No significant differences were observed between the distribution of -786T>C polymorphism and other investigated markers.

Vitamin D₃ (VD₃) is shown to be a biochemical and physiological modulator of the body. Debates about route of administration, prescribed dosage and serum levels have arisen, and thus the interaction of VD₃ with the body in overdose. Using an experimental model of Wistar rats of both sexes, rats were subdivided into 5 groups, which represents a control group, and 4 groups with VD₃ treatments (2.500, 7.000, 14.000 and 21.000 IU/kg/week) for one month. Thereafter biochemical, hormonal, inflammatory and histological analyses were performed. Regarding the biochemical findings, there was an increase in the levels of the AST in comparison of the control group with the treatments with higher doses (14.000 IU and 21.000 IU). Furthermore, changes in the inflammatory cytokine profile were identified at doses of 14,000 IU and 21,000 IU, with an increase in inflammatory cytokines (IL-1β, IL-6, IL-8 and TNF-α) and a decrease in the anti-inflammatory IL-10. Histological evaluation of the liver tissue also revealed changes at the highest doses. Finally, in the evaluation of a murine physiological model, it showed that the supplementation of VD₃ in overdoses there was an inflammatory exacerbation in the body, suggesting that the VD₃ supplementation should be administered with caution, and takes into account physiological factors of the individual.

This study aimed to evaluate the effects of C. sinensis extract, orlistat, and their combination on biochemical, hormonal, inflammatory, and oxidative stress parameters in female rats. The extract was characterized by the presence of citric acid, ferulic acid, and quercetin, along with antioxidant activity. Five experimental groups were established: (1) control; (2) obese; (3) orlistat (1.72 mg/kg); (4) C. sinensis extract (7.15 mg/kg); (5) a combination of both treatments. Treatment with the extract, orlistat, or their combination resulted in biochemical parameters (glucose, cholesterol, and triglycerides) that were comparable to the control group and significantly different from the obese group. Notably, only the C. sinensis extract alone restored pro-inflammatory cytokine levels (IL-1β, TNF-α, IL-6, IL-8) to values similar to the control. All treatments improved the activity of antioxidant enzymes catalase and glutathione peroxidase, while a significant increase in superoxide dismutase activity was observed only in the extract group. Among the oxidative damage markers, TBARS was the most responsive to treatment, whereas protein carbonylation was less affected. Histological analysis showed that all treatments promoted structural normalization. These results provide a rationale for further pre-clinical and clinical investigations into the use of C. sinensis extract as an adjunctive therapy for metabolic disorders.